Finance

Lists
300558:SHE
Betta Pharmaceuticals Co Ltd
CNÂ¥50.48
-0.14%
(-0.070) 1D
Aug 31, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300558...
Open
CNÂ¥50.01
High
CNÂ¥50.49
Low
CNÂ¥49.03
Mkt. cap
21.40B
Avg. vol.
18.71M
Volume
9.28M
Dividend
0.30%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
45.36
52-wk high
CNÂ¥79.80
52-wk low
CNÂ¥40.10
EPS
CNÂ¥1.11
Shares outstanding
423.33M
No. of employees
2K
Open
CNÂ¥50.01
High
CNÂ¥50.49
Low
CNÂ¥49.03
Mkt. cap
21.40B
Avg. vol.
18.71M
Volume
9.28M
Dividend
0.30%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
45.36
52-wk high
CNÂ¥79.80
52-wk low
CNÂ¥40.10
EPS
CNÂ¥1.11
Shares outstanding
423.33M
No. of employees
2K
About Betta Pharmaceuticals Co Ltd
CEO-
Employees1.78K
FoundedJan 7, 2003
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
985.93M
892.00M
1.04B
936.09M
Cost of goods sold
208.48M
204.34M
217.50M
248.14M
Cost of revenue
208.48M
204.34M
217.50M
248.14M
Research and development expenses
118.31M
137.90M
97.44M
119.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
447.07M
477.36M
422.85M
465.85M
Operating expense
578.16M
625.07M
526.01M
606.92M
Total operating expenses
786.65M
829.41M
743.50M
855.05M
Operating income
199.28M
62.58M
296.33M
81.04M
Other non operating income
-8.80M
6.81M
-10.30M
8.81M
EBT including unusual items
203.76M
22.79M
282.47M
85.85M
EBT excluding unusual items
181.48M
38.51M
268.61M
54.28M
Income tax expense
31.46M
39.59M
51.31M
24.32M
Effective tax rate
15.44%
173.71%
18.16%
28.33%
Other operating expenses
13.08M
9.32M
6.34M
16.52M
Net income
177.04M
-11.60M
235.92M
66.22M
Net profit margin
17.96%
-1.30%
22.69%
7.07%
Earnings per share
-
-
-
-
Interest and investment income
862.68K
369.02K
564.57K
445.21K
Interest expense
-18.62M
-18.62M
-17.98M
-18.50M
Net interest expenses
-17.76M
-18.25M
-17.41M
-18.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
291.32M
199.56M
433.31M
220.30M
Gain or loss from assets sale
72.94K
-377.65K
-
344.11K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps